TY - JOUR
T1 - Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation
T2 - An Expert Opinion
AU - Sisinni, Antonio
AU - Taramasso, Maurizio
AU - Praz, Fabien
AU - Metra, Marco
AU - Agricola, Eustachio
AU - Margonato, Alberto
AU - Fam, Neil
AU - Estevez-Loureiro, Rodrigo
AU - Latib, Azeem
AU - Messika-Zeitoun, David
AU - Conradi, Lenard
AU - von Bardeleben, Ralph Stephan
AU - Sorajja, Paul
AU - Hahn, Rebecca T.
AU - Caravita, Sergio
AU - Maisano, Francesco
AU - Adamo, Marianna
AU - Godino, Cosmo
N1 - Publisher Copyright:
© 2023 American College of Cardiology Foundation
PY - 2023/1/23
Y1 - 2023/1/23
N2 - Secondary (functional) tricuspid regurgitation (sTR) is common in patients with mitral regurgitation (MR). Because combined valvular heart disease affects long-term survival, in comparison with isolated MR or tricuspid regurgitation, it is essential to offer patients adequate treatment. Despite considerable experience, no conclusive data are yet available on the prognostic impact of concomitant tricuspid valve surgery at the time of mitral valve surgery. Emerging transcatheter treatments offer the opportunity to treat both conditions (MR and sTR) simultaneously or in a stepwise fashion. This review provides a clinical overview on available data regarding the rationale for treatment of sTR in patients with relevant MR undergoing mitral transcatheter edge-to-edge repair, focusing on clinical and anatomical selection criteria.
AB - Secondary (functional) tricuspid regurgitation (sTR) is common in patients with mitral regurgitation (MR). Because combined valvular heart disease affects long-term survival, in comparison with isolated MR or tricuspid regurgitation, it is essential to offer patients adequate treatment. Despite considerable experience, no conclusive data are yet available on the prognostic impact of concomitant tricuspid valve surgery at the time of mitral valve surgery. Emerging transcatheter treatments offer the opportunity to treat both conditions (MR and sTR) simultaneously or in a stepwise fashion. This review provides a clinical overview on available data regarding the rationale for treatment of sTR in patients with relevant MR undergoing mitral transcatheter edge-to-edge repair, focusing on clinical and anatomical selection criteria.
KW - concomitant treatment
KW - mitral regurgitation
KW - secondary tricuspid regurgitation
KW - transcatheter mitral valve repair
KW - tricuspid transcatheter edge-to-edge repair
UR - http://www.scopus.com/inward/record.url?scp=85146275205&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146275205&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2022.11.022
DO - 10.1016/j.jcin.2022.11.022
M3 - Review article
C2 - 36697147
AN - SCOPUS:85146275205
SN - 1936-8798
VL - 16
SP - 127
EP - 139
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 2
ER -